{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:32:00Z","timestamp":1783427520763,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T00:00:00Z","timestamp":1414540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00520-014-2484-9","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T09:44:02Z","timestamp":1414489442000},"page":"1355-1364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia"],"prefix":"10.1007","volume":"23","author":[{"given":"John M.","family":"Salsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Wortman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"2484_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"2484_CR2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0148607188012003286","volume":"12","author":"K Kern","year":"1988","unstructured":"Kern K, Norton J (1988) Cancer cachexia. JPEN J Parenter Enteral Nutr 12:286\u2013298","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2484_CR3","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","volume":"45","author":"N Johns","year":"2013","unstructured":"Johns N, Stephens NA, Fearon KCH (2013) Muscle wasting in cancer. Int J Biochem Cell Biol 45:2215\u20132229","journal-title":"Int J Biochem Cell Biol"},{"key":"2484_CR4","unstructured":"World Health Organization (2013) Cancer - Fact sheet No. 297. In: Editor (ed)^(eds) Book Cancer - Fact sheet No. 297, City"},{"key":"2484_CR5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2009.25.4052","volume":"28","author":"AJ Davidoff","year":"2010","unstructured":"Davidoff AJ, Tang M, Seal B, Edelman MJ (2010) Chemotherapy and survival benefit in elderly patients with advanced non-small cell lung cancer. J Clin Oncol 28:2191\u20132197","journal-title":"J Clin Oncol"},{"key":"2484_CR6","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O\u2019Brien MER (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90:1905\u20131911","journal-title":"Br J Cancer"},{"key":"2484_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/NJH.0b013e31825f3470","volume":"14","author":"C Ferraro Del","year":"2012","unstructured":"Del Ferraro C, Grant M, Koczywas M, Dorr-Uyemura LA (2012) Management of anorexia-cachexia in late-stage lung cancer patients. J Hosp Palliat Nurs 14:397\u2013402","journal-title":"J Hosp Palliat Nurs"},{"key":"2484_CR8","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","volume":"21","author":"O Wallengren","year":"2013","unstructured":"Wallengren O, Lundholm K, Bosaeus I (2013) Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 21:1569\u20131577","journal-title":"Support Care Cancer"},{"key":"2484_CR9","doi-asserted-by":"crossref","unstructured":"Currow DC, Abernethy AP (2014) Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome Future Oncol: 1\u201314","DOI":"10.2217\/fon.14.14"},{"key":"2484_CR10","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1200\/jco.2007.25.18_suppl.9133","volume":"18","author":"J Garcia","year":"2007","unstructured":"Garcia J, Boccia RV, Graham C, Kumor K, Polvino W (2007) A phase II randomized, placebo-controlled, double-blind study of the efficacy and safety of RC-1291 (RC) for the treatment of cancer cachexia. J Clin Oncol 18:9133","journal-title":"J Clin Oncol"},{"key":"2484_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","volume":"21","author":"J Garcia","year":"2013","unstructured":"Garcia J, Friend J, Allen S (2013) Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer 21:129\u2013137","journal-title":"Support Care Cancer"},{"key":"2484_CR12","unstructured":"Temel J, Bondarde S, Jain M, Allen S, Mann W (2013) Efficacy and safety of anamorelin HCl in NSCLC patients: results from a randomized, double-blind, placebo-controlled, multicenter phase II study. European Cancer Congress. Amsterdam, The Netherlands,1308 In: Editor (ed)^(eds) Book Efficacy and safety of anamorelin HCl in NSCLC patients: results from a randomized, double-blind, placebo-controlled, multicenter phase II study. European Cancer Congress. Amsterdam, The Netherlands,1308 City"},{"key":"2484_CR13","doi-asserted-by":"crossref","unstructured":"Temel J, Bondarde S, Jain M, Yan Y, Duus EM, Allen S, Mann W (2013) Evaluation of quality of life from a phase II study of anamorelin HCl in NSCLC patients. 2013 ASCO\u2019s Quality Care Symposium. In: Editor (ed)^(eds) Book Evaluation of quality of life from a phase II study of anamorelin HCl in NSCLC patients. 2013 ASCO\u2019s Quality Care Symposium, City","DOI":"10.1200\/jco.2013.31.31_suppl.42"},{"key":"2484_CR14","doi-asserted-by":"crossref","unstructured":"Abernethy AP, Temel JS, Currow D (2013) Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia. In: Editor (ed)^(eds) Book Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia, City","DOI":"10.1200\/jco.2013.31.15_suppl.tps9649"},{"key":"2484_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1037\/h0025759","volume":"77","author":"S Grand","year":"1968","unstructured":"Grand S (1968) Color-word interference: an investigation of the role of vocal conflict and hunger in associative priming. J Exp Psychol 77:31\u201340","journal-title":"J Exp Psychol"},{"key":"2484_CR16","doi-asserted-by":"crossref","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology 11:570\u2013579","DOI":"10.1200\/JCO.1993.11.3.570"},{"key":"2484_CR17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pmrj.2010.04.017","volume":"2","author":"E Smith","year":"2010","unstructured":"Smith E, Lai JS, Cella D (2010) Building a measure of fatigue: the functional assessment of chronic illness therapy fatigue scale. PM R 2:359\u2013363","journal-title":"PM R"},{"key":"2484_CR18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1016670403148","volume":"9","author":"JM Ribaudo","year":"2000","unstructured":"Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, Leslie WT (2000) Re-validation and shortening of the Functional Assessment of Anorexia\/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 9:1137\u20131146","journal-title":"Qual Life Res"},{"key":"2484_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","volume":"24","author":"D Cella","year":"2002","unstructured":"Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manag 24:547\u2013561","journal-title":"J Pain Symptom Manag"},{"key":"2484_CR20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","volume":"57","author":"D Eton","year":"2004","unstructured":"Eton D, Cella D, Yount S, Peterman A, Neuberg D, Sledge GW, Wood W (2004) A combination of distribution and anchor-based approaches determined minimally important differences (MIDs) for four endpoints ina breast cancer scale. J Clin Epidemiol 57:898\u2013910","journal-title":"J Clin Epidemiol"},{"key":"2484_CR21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jclinepi.2010.11.018","volume":"64","author":"KJ Yost","year":"2011","unstructured":"Yost KJ, Eton DT, Garcia SF, Cella D (2011) Minimally important differences were estimated for six patient-reported outcomes measurement information system-cancer scales in advanced-stage cancer patients. J Clin Epidemiol 64:507\u2013516","journal-title":"J Clin Epidemiol"},{"key":"2484_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13:63\u201374","journal-title":"J Pain Symptom Manag"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2484-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2484-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2484-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T05:35:33Z","timestamp":1598420133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2484-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2484"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2484-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}